These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4313025)

  • 1. Differential sensitivity to gliotoxin of virulent and attenuated poliovirus strains and its possible use as a genetic marker.
    Sergiescu D; Aubert-Combiescu A
    Arch Gesamte Virusforsch; 1969; 27(2):268-81. PubMed ID: 4313025
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential sensitivity of virulent and attenuated strains of type 1 poliovirus to polyethylene glycol as a possible new genetic marker.
    Lokteva VF; Chumakov MP; Zhevandrova VI; Shekoyan LA
    Arch Gesamte Virusforsch; 1973; 41(3):155-9. PubMed ID: 4353792
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral activity of gliotoxin.
    Larin NM; Copping MP; Herbst-Laier RH; Roberts B; Wenham RB
    Chemotherapy; 1965; 10(1):12-23. PubMed ID: 4285752
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral action of gliotoxin.
    McDougall JK
    Arch Gesamte Virusforsch; 1969; 27(2):255-67. PubMed ID: 4313024
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinctive features and comparative value of the genetic markers defining the behaviour of poliovirus towards different selective inhibitors.
    Horodniceanu F; Sergiescu D; Aubert-Combiescu A; Crainic R
    Prog Immunobiol Stand; 1967; 3():78-81. PubMed ID: 4314440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reduction of virulence by dichloroisocyanuric acid sodium salt and detergent compositions on its base with reference to enteroviruses].
    Shirobokov VP; Nikitenko AG; Iakimenko AI
    Mikrobiol Zh; 1975; 37(2):205-11. PubMed ID: 175249
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral phenoxathiins and their analogs. Study of the structure-activity relationships for antiviral activity and the replacement ability in poliovirus type 3 dependent variants.
    Paget CJ; Dennis EM; Nelson J; DeLong DC
    J Med Chem; 1970 Jul; 13(4):620-3. PubMed ID: 4318071
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavior of poliovirus towards dextran sulphate and relationship between this character and other genetic markers.
    Sergiescu D; Horodniceanu F; Crainic R
    Arch Roum Pathol Exp Microbiol; 1967 Jun; 26(2):453-63. PubMed ID: 4298003
    [No Abstract]   [Full Text] [Related]  

  • 9. Aluminum-marker of wild type 1 poliovirus strains.
    Nakao C; Tagaya I; Komatsu T; Kodama H
    Jpn J Microbiol; 1970 Sep; 14(5):405-12. PubMed ID: 4319729
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of isatin beta thiosemicarbazone (IBT)-related compounds on IBT-resistant and on IBT-dependent mutants of vaccinia virus.
    Katz E; Margalith E; Winer B
    J Gen Virol; 1974 Nov; 25(2):239-44. PubMed ID: 4373528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibiting action of gliotoxin on the development of poliovirus I in vitro].
    Maxia L; La Colla P; Palmas F; Serra L; Querzola F; Loddo B
    Boll Soc Ital Biol Sper; 1969 Aug; 45(15):1061-4. PubMed ID: 4315985
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiviral properties of 1-allyl and 1-crotyl derivatives of 2-( -hydroxybenzyl) benzimidazole.
    O'Sullivan DG; Ludlow CM
    Experientia; 1972 Aug; 28(8):889-90. PubMed ID: 4342512
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effect of N-phenyl-N'-aryl or alkylthiourea derivatives on poliovirus multiplication in cell cultures.
    Galabov A; Shindarov L; Vassilev G; Vassileva R
    Chemotherapy; 1972; 17(3):161-74. PubMed ID: 4338370
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the antiviral activity of formycin.
    Ishida N; Homma M; Kumagai K; Shimizu Y; Matsumoto S
    J Antibiot (Tokyo); 1967 Jan; 20(1):49-52. PubMed ID: 4292904
    [No Abstract]   [Full Text] [Related]  

  • 15. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
    Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
    Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiviral activity of imidazole derivatives. IV. Sensitivity of different viruses].
    Tonew M; Tonew EM; Zöpel P
    Arch Gesamte Virusforsch; 1971; 34(3):250-4. PubMed ID: 4330139
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of phleomycin on poliovirus RNA replication.
    Hecht TT; Summers DF
    Virology; 1970 Mar; 40(3):441-7. PubMed ID: 4314502
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of resistance to antiviral drugs.
    Renis HE; Buthala DA
    Ann N Y Acad Sci; 1965 Jul; 130(1):343-54. PubMed ID: 4285582
    [No Abstract]   [Full Text] [Related]  

  • 19. Problems associated with the study of spontaneous mutation towards guanidine resistance in poliovirus.
    Aubert-Combiescu A; Sergiescu D
    Prog Immunobiol Stand; 1967; 3():82-3. PubMed ID: 4314441
    [No Abstract]   [Full Text] [Related]  

  • 20. The specific effectors of viral development.
    Lwoff A
    Biochem J; 1965 Aug; 96(2):289-301. PubMed ID: 4284431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.